Life Sciences Ecosystem
in the United Arab Emirates 2023 (Beta Version)
Science, Technology, Medicine, Investment, Policy
The Life Sciences Division of Deep Knowledge Group has compiled an analytical case study titled "Life Sciences in the United Arab Emirates." The primary objective of this report is to offer a more comprehensive perspective on the current state of the Life Sciences Ecosystem in the UAE, with a particular focus on the involvement of new entities.
The United Arab Emirates is clearly on a path of evolution and growth in the field of life sciences, presenting a promising landscape for the launch of fresh initiatives. Additionally, there is a noticeable trend of increased international collaborations, resulting in a greater inflow of funding from both domestic and foreign sources.
At the heart of our report lies a foundation of data rooted in scientific and clinical evidence. This information can prove invaluable to healthcare professionals, research and development experts, as well as investors in the Life Sciences Industry within the UAE.
Explore the "Life Sciences in the United Arab Emirates 2023" for an in-depth analysis of cutting-edge technologies in the life science field, comprehensive market trend analysis, and a breakdown of regional market segments.
Uncover the connections between the UAE's geography, politics, and other unique attributes and their impact on the life science sector. Join us on this platform for expert insights into a rapidly growing and dynamic industry.
Key Parameters
BETA VERSION
Key Insights
Increased International Collaboration in the UAE Patents in Life Sciences
Geographical Distribution of the Partnerships of the UAE Patents
In the field of life sciences, the UAE boasts a significant 1,032 patents, notable for their robust international collaborations. A substantial 37% of these patents involve partnerships with European Union entities, highlighting a strong global knowledge exchange.
The United States also plays a leading role with 25% of patents, while Japan (6%), South Korea (3%), and Canada (2%) actively contribute. This international cooperation reflects the UAE's commitment to advancing global life sciences.
Milestones in the International Collaboration in the UAE Patents in Life Sciences
The UAE is experiencing a surge in international collaboration within the field of life sciences. Notably, the country embarked on the production of a COVID-19 vaccine through a partnership between Sinopharm CNBG and Abu Dhabi's G42, marking a significant milestone in Arab nations. The nation's commitment to advancing healthcare is further exemplified by partnerships like the one between MBZUAI and Quris-AI, which has established a cutting-edge Bio-AI center for the development of personalized medications using artificial intelligence. Additionally, various collaborations with renowned institutions like Mayo Clinic, Sheba Medical Center, and BridgeBio Pharma are propelling the UAE's medical landscape forward, fostering innovation and global logistics expansion in the realm of healthcare.
Dynamics of the UAE Patents in Life Sciences Registration Over the Years
The UAE is experiencing a surge in international collaboration within the field of life sciences.
Notably, the country embarked on the production of a COVID-19 vaccine through a partnership between Sinopharm CNBG and Abu Dhabi's G42, marking a significant milestone in Arab nations.
The nation's commitment to advancing healthcare is further exemplified by partnerships like the one between MBZUAI and Quris-AI, which has established a cutting-edge Bio-AI center for the development of personalized medications using artificial intelligence.
Additionally, various collaborations with renowned institutions like Mayo Clinic, Sheba Medical Center, and BridgeBio Pharma are propelling the UAE's medical landscape forward, fostering innovation and global logistics expansion in the realm of healthcare.
